View Older Stories View More Recent Stories

Jul 18, 2019 06:42AM TETRA Technologies Inc. (TTI) PT Lowered to $4 at RBC Capital
Jul 18, 2019 06:41AM Select Energy Services (WTTR) PT Lowered to $14 at RBC Capital
Jul 18, 2019 06:40AM Noble Corporation (NE) PT Lowered to $13 at RBC Capital
Jul 18, 2019 06:40AM Netflix (NFLX) PT Lowered to $450 at RBC Capital
Jul 18, 2019 06:39AM National-Oilwell Varco (NOV) PT Lowered to $27 at RBC Capital
Jul 18, 2019 06:38AM Halliburton (HAL) PT Lowered to $39 at RBC Capital
Jul 18, 2019 06:37AM ENSCO International Plc (ESV) PT Lowered to $34 at RBC Capital
Jul 18, 2019 06:37AM eBay (EBAY) PT Raised to $38 at RBC Capital
Jul 18, 2019 06:35AM Diamond Offshore (DO) PT Lowered to $20 at RBC Capital
Jul 18, 2019 06:35AM Covia Holdings Corp (CVIA) PT Lowered to $5 at RBC Capital
Jul 18, 2019 06:34AM Core Laboratories (CLB) PT Lowered to $75 at RBC Capital
Jul 18, 2019 06:33AM Comerica (CMA) PT Lowered to $86 at RBC Capital
Jul 18, 2019 06:32AM Abbott Labs (ABT) PT Raised to $92 at RBC Capital
Jul 18, 2019 06:32AM UPDATE: RBC Capital Downgrades ExxonMobil (XOM) to Sector Perform
Jul 18, 2019 06:29AM RBC Capital Starts Diamondback Energy (FANG) at Outperform
Jul 18, 2019 06:00AM Compass Datacenters Announces $3 Billion Expansion Plan
Jul 18, 2019 06:00AM Compass Datacenters Announces $3 Billion Expansion Plan
Jul 18, 2019 05:59AM Genmab A/S (GEN) Prices 28.5M ADS IPO at $17.75/ADS
Jul 18, 2019 03:58AM RBC Capital Downgrades Whitbread PLC. (WTB:LN) (WTBCF) to Underperform
Jul 18, 2019 03:57AM RBC Capital Downgrades Vermilion Energy (VET:CN) (VET) to Sector Perform
Jul 18, 2019 03:57AM RBC Capital Downgrades InterContinental Hotels Group (IHG:LN) (IHG) to Underperform
Jul 17, 2019 08:36PM Medical Properties Trust Announces Upsizing and Pricing of $900.0 Million of 4.625% Senior Notes Due 2029
Jul 17, 2019 08:30PM Genmab Prices its Initial Public Offering of American Depositary Shares (ADSs) in the United States
Jul 17, 2019 08:30PM Genmab Prices its Initial Public Offering of American Depositary Shares (ADSs) in the United States
Jul 17, 2019 06:10PM Owl Rock Capital Corporation Prices Public Offering
Jul 17, 2019 08:10AM Gilead Sciences (GILD) Has Low Expectations Option In GLPG1690 - RBC Capital
Jul 17, 2019 07:40AM Medical Properties Trust Announces Full Exercise of Over-Allotment Option in Follow-On Offering of Common Stock
Jul 17, 2019 07:26AM Medical Properties Trust Announces Public Offering of $750.0 Million of Senior Notes Due 2029
Jul 17, 2019 07:13AM Wintrust Financial (WTFC) PT Lowered to $82 at RBC Capital
Jul 17, 2019 07:13AM Turquoise Hill Resources (TRQ:CN) (TRQ) PT Lowered to $2 at RBC Capital
Jul 17, 2019 06:47AM Seattle Genetics (SGEN) PT Raised to $80 at RBC Capital
Jul 17, 2019 06:46AM First Republic Bank (FRC) PT Lowered to $95 at RBC Capital
Jul 17, 2019 06:45AM First Horizon National (FHN) PT Raised to $17 at RBC Capital
Jul 17, 2019 06:44AM CSX (CSX) PT Lowered to $75 at RBC Capital
Jul 17, 2019 06:43AM Cintas (CTAS) PT Raised to $267 at RBC Capital
Jul 17, 2019 06:41AM UPDATE: RBC Capital Downgrades Lear (LEA) to Sector Perform
Jul 16, 2019 01:44PM CarMax (KMX) CAF Remains 'Relatively Steady' - RBC
Jul 16, 2019 08:00AM Mereo BioPharma Appoints Richard Francis as Head of Pharmaceutical Development
Jul 16, 2019 08:00AM Mereo BioPharma Appoints Richard Francis as Head of Pharmaceutical Development
Jul 16, 2019 07:30AM BlackBerry Limited (BB) Offers Good Risk/Reward, NDR Thoughts - RBC
Jul 16, 2019 07:14AM Micron Technology (MU) Could Gain Share in the Wake of the Japan/Korea Dispute - RBC
Jul 16, 2019 06:08AM Cameco Corp. (CCO:CN) (CCJ) PT Lowered to Cdn$14 at RBC Capital
Jul 16, 2019 05:42AM Medical Properties Trust (MPW) Prices 45M Share Common Offering at $17.29/Sh
Jul 16, 2019 04:03AM Hastings Group Holdings Plc. (HSTG:LN) PT Lowered to GBp200 at RBC Capital
Jul 16, 2019 04:03AM Adidas AG (ADS:GR) (ADDYY) PT Raised to EUR305 at RBC Capital
Jul 15, 2019 11:14PM Medical Properties Trust Announces Pricing of Public Offering of Common Stock
Jul 15, 2019 04:05PM AquaVenture Announces Closing of Public Offering of Ordinary Shares and Full Exercise of Underwriters’ Option
Jul 15, 2019 08:06AM Mereo BioPharma (MREO) Announces Successful Type B Meeting with FDA, Outlines Accelerated Approval Pathway for Navicixizumab
Jul 15, 2019 08:00AM Mereo BioPharma Announces Successful Type B Meeting with U.S. FDA and Outlines Accelerated Approval Pathway for Navicixizumab in Advanced Ovarian Cancer
Jul 15, 2019 08:00AM Mereo BioPharma Announces Successful Type B Meeting with U.S. FDA and Outlines Accelerated Approval Pathway for Navicixizumab in Advanced Ovarian Cancer
View More Recent Stories View Older Stories